David C. Karli, Founder and CEO of Greyledge Technologies, believes his business is unique because of the potential to integrate his biologics program clinically and from a research pathway together. They do cases, process samples, and coordinate closely with their team of researchers to not only define what they are doing but to create best practices. Karli’s aim is patient-focused by seeking to educate other clinicians about what they are doing and how they are doing it.
Learn more about Greyledge Technologies and David C. Karli HERE.
The post Why David C. Karli’s Business is Unique appeared first on Grant Cardone TV.